R&O Pharmacy

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were down more than 25 percent following reports from Citron Research and SIRF that the company is engaged in questionable sales and accounting practices. The crux of Citron Research's short thesis is that R&O Pharmacy, which filed...